Morgan Stanley
ASPX

Morgan Stanley’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Morgan Stanley’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-42,464
Closed -$4.26M – 6968
2015
Q1 		$4.26M Buy
42,464
+24,093
+131% +$1.6M ﹤0.01% 2896
2014
Q4 		$964K Buy
18,371
+16,720
+1,013% +$491K ﹤0.01% 4181
2014
Q3 		$42K Sell
1,651
-39,307
-96% -$836K ﹤0.01% 5792
2014
Q2 		$912K Sell
40,958
-33,419
-45% -$731K ﹤0.01% 4129
2014
Q1 		$2.29M Buy
+74,377
New +$2M ﹤0.01% 3301

Morgan Stanley's ASPX Position: Q2 2015 in Review

Morgan Stanley sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 42,464 shares — an estimated $4.26M sold.

Morgan Stanley first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $4.26M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Morgan Stanley reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Morgan Stanley sold 42,464 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $4.26M.
  • Morgan Stanley first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Morgan Stanley's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $4.26M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.